Epilepsy, Post-Traumatic: Clinical Trials

3 trials for Epilepsy, Post-Traumatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1

Follow Epilepsy, Post-Traumatic: new trials by email Literature Review of Epilepsy, Post-Traumatic trials Research Report on Epilepsy, Post-Traumatic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy
PO BRC-003 (High Cannabidiol Cannabis Extract), Placebo - Post-traumatic Epilepsy
Phase 2WithdrawnDr. Paul Lyons2024-11-012025-04-24
Allopregnanolone for the Treatment of Traumatic Brain Injury
Allopregnanolone injection, Placebo injection - Traumatic Brain Injury, Posttraumatic Epilepsy
Phase 2CompletedMichael A. Rogawski, MD, PhD132013-04-012017-06-28
Levetiracetam to Prevent Post-Traumatic Epilepsy
Levetiracetam - Epilepsy, Post-traumatic Epilepsy
Phase 2CompletedPavel Klein1262005-04-012016-01-13

Narrower conditions

Brain Injuries, Traumatic (2)  ·  Epilepsy (2)  ·  Brain Injuries (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Craniocerebral Trauma (3)  ·  Nervous System Diseases (3)  ·  Trauma, Nervous System (3)  ·  Wounds and Injuries (3)  ·  Brain Injuries (2)  ·  Epilepsy (1)

Interventions

Cannabinoids (1)  ·  Levetiracetam (1)  ·  Pregnanolone (1)  ·  nabiximols (1)

Sponsors

Dr. Paul Lyons (1)  ·  Michael A. Rogawski, MD, PhD (1)  ·  Pavel Klein (1)

Countries

United States (3)

Top investigators

JoAnne E Natale, MD, PhD (1)  ·  Michael A Rogawski, MD, PhD (1)  ·  Paul D Lyons, MD. PhD (1)  ·  Pavel Klein, M.D. (1)

Results publications

PMID 22771222, PMID 22777131, PMID 23876024